LKQ vs RNAZ · P/E 14, rev $6.88B vs $5.1M cap
LKQ Corporation (LKQ) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
LKQ Corporation (LKQ) is a auto parts company listed on US.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported LKQ revenue for 2026-06-30 was $6.88B. Net income was $215.0M. Revenue was up 98.2% from 2026-03-31 to 2026-06-30. LKQ currently screens at market cap $9.99B and trailing P/E 14.4.
RNAZ does not have a complete income-statement cache yet.
LKQ currently screens at market cap $9.99B and trailing P/E 14.4. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the LKQ and RNAZ stock pages for the full models.
Not investment advice.